Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Type 2 diabetes impairs venous, but not arterial smooth muscle cell function: possible role of differential RhoA activity.

Cardiovascular revascularization medicine : including molecular interventions - 1 Apr 2014

Riches Kirsten, Warburton Philip, O'Regan David J, Turner Neil A, Porter Karen E

Abstract excerpt

BACKGROUND/PURPOSE: Coronary heart disease is the leading cause of morbidity in patients with type 2 diabetes mellitus (T2DM), frequently resulting in a requirement for coronary revascularization using the internal mammary artery (IMA) or saphenous vein (SV). Patency rates of SV grafts are inferior to IMA and further impaired by T2DM whilst IMA patencies appear similar in both populations. Smooth muscle cells...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Shape
Share to Diabetes Mellitus, Type 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diabetic Angiopathies

Share to Down-Regulation

Share to Muscle, Smooth, Vascular

Share to Myocytes, Smooth Muscle

Share to rhoA GTP-Binding Protein

Share to Saphenous Vein

Source

Identifiers

PMID: 24642103
DOI: 10.1016/j.carrev.2014.02.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Type 2 diabetes impairs venous, but not arterial smooth muscle cell function: possible role of differential RhoA activity.PMID 24642103Read ↗

Elevated expression levels of miR-143/5 in saphenous vein smooth muscle cells from patients with Type 2 diabetes drive persistent changes in phenotype and function.Semantic proximity Read ↗

Vascular Smooth Muscle as a Target for Novel Therapeutics.Semantic proximity Read ↗

Role of RhoA and Rho-associated kinase in phenotypic switching of vascular smooth muscle cells: Implications for vascular function.Semantic proximity Read ↗

Integrative Analysis of Gene Expression, Protein Abundance, and Metabolomic Profiling Elucidates Complex Relationships in Chronic Hyperglycemia-Induced Changes in Human Aortic Smooth Muscle CellsSemantic proximity Read ↗

Role and mechanisms of vascular smooth muscle cell phenotypic transition in diabetic macrovascular complications.Semantic proximity Read ↗

Aberrant phenotype in human endothelial cells of diabetic origin: implications for saphenous vein graft failure?Semantic proximity Read ↗

Regulation of Vascular Smooth Muscle Cell Dysfunction Under Diabetic Conditions by miR-504.Semantic proximity Read ↗

Phenotype modulation in primary cultures of aortic smooth muscle cells from streptozotocin-diabetic rats.Semantic proximity Read ↗

Implications of autophagy for vascular smooth muscle cell function and plasticitySemantic proximity Read ↗

Calcineurin-mediated pathway involved in the differentiated phenotype of smooth muscle cells.Semantic proximity Read ↗

Phenotype-specific inhibition of the vascular smooth muscle cell cycle by high glucose treatment.Semantic proximity Read ↗

MiR-138 promotes smooth muscle cells proliferation and migration in db/db mice through down-regulation of SIRT1Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.